A comprehensive map of the SARS-CoV-2 genome
MIT researchers have determined the virus’ protein-coding gene set and analyzed new mutations’ likelihood of helping the virus adapt.
MIT researchers have determined the virus’ protein-coding gene set and analyzed new mutations’ likelihood of helping the virus adapt.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Study suggests this process for eliminating unneeded cells may also protect against cancer.
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged.
Caroline Uhler blends machine learning, statistics, and biology to understand how our bodies respond to illness.
Encapsulating modified bacteria in tough hydrogel spheres prevents them from spreading genes to other microbes.
International study reveals gut bacteria from people in industrialized societies swap genes at much higher rates.
Varying levels of a DNA repair enzyme can lead to very different outcomes after exposure to NDMA.
C. elegans compares the ratio of wavelengths in its environment to avoid dangerous bacteria that secrete colorful toxins.
The gene variant disrupts lipid metabolism, but in cell experiments the effects were reversed by choline supplements.
Kano Therapeutics was one of eight finalists to pitch at the virtual competition.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.
MIT senior will pursue graduate studies at Cambridge University.
Study suggests forcing bacteria to burn more energy could make them more susceptible to antibiotics.